Polaris

IPO

Public · $10.0M raised

Business Model
B2B
Total Funding
$10.0M
Last Round
$10.0M Series ASep 2016
Rounds
1
Type
Public

About

Is a multinational biopharmaceutical drug company

Summary

Polaris is a Biotech company. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Sep 2016. Investors include SAIF Partners.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ASep 2016
$10.0M

Investors

Similar Companies